Lambdin, Barrot H.
Wenger, Lynn
Bluthenthal, Ricky
Bartholomew, Tyler S.
Tookes, Hansel E.
LaKosky, Paul
O’Neill, Savannah
Kral, Alex H.
Funding for this research was provided by:
National Institute on Drug Abuse (5R01DA046867, 5R01DA046867, 5R01DA046867, 5R01DA046867, 5R01DA046867, 5R01DA046867)
Article History
Received: 23 October 2022
Accepted: 9 February 2023
First Online: 28 February 2023
Declarations
:
: Our study procedures were reviewed by internal review board within the Office of Research Protection at RTI International’s internal review board and was determined to be exempt under 45 CFR 46.104 (d)(2)(ii). Yet, the study did include a consent process which disclosed the activities of the research, the procedures to be performed, that participation was voluntary, the investigator name and contact information and the provisions to maintain the privacy of subjects. Because the study was determined to be exempt, the consent process did not require a written or electronic signature or a waiver of written documentation of consent. However, participants had to indicate their consent to participate by selecting a button on the webpage before advancing into the online survey.
: Not applicable.
: The authors declare that they have no competing interests.